迈瑞医疗
(300760)
| 流通市值：2746.13亿 | | | 总市值：2746.18亿 |
| 流通股本：12.12亿 | | | 总股本：12.12亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 8,237,179,005 | 36,725,749,548 | 29,484,805,493 | 20,530,596,799 |
| 营业收入 | 8,237,179,005 | 36,725,749,548 | 29,484,805,493 | 20,530,596,799 |
| 二、营业总成本 | 5,312,791,042 | 24,096,446,217 | 17,867,270,338 | 12,390,670,510 |
| 营业成本 | 3,086,814,486 | 13,547,519,384 | 10,358,523,254 | 6,928,401,101 |
| 税金及附加 | 101,576,655 | 400,539,455 | 314,817,220 | 222,224,136 |
| 销售费用 | 1,178,303,701 | 5,282,806,736 | 3,664,616,797 | 2,934,958,832 |
| 管理费用 | 341,910,867 | 1,599,747,932 | 1,119,339,140 | 822,534,756 |
| 研发费用 | 766,538,112 | 3,665,860,585 | 2,592,345,180 | 1,775,300,575 |
| 财务费用 | -162,352,779 | -400,027,875 | -182,371,253 | -292,748,890 |
| 其中:利息费用 | 4,987,662 | 19,413,638 | 14,197,335 | 9,131,150 |
| 其中:利息收入 | 114,347,050 | 557,483,566 | 434,205,071 | 316,357,754 |
| 加:公允价值变动收益 | - | 126,027,776 | 126,883,062 | 126,284,421 |
| 加:投资收益 | 96,084,286 | 69,390,139 | 64,217,177 | 63,439,016 |
| 资产处置收益 | -1,080,485 | 4,243,844 | 7,932,009 | 3,540,498 |
| 资产减值损失(新) | -42,890,136 | -237,841,474 | -161,030,640 | -91,139,728 |
| 信用减值损失(新) | -101,167,194 | -299,628,516 | -188,199,618 | -134,331,607 |
| 其他收益 | 172,742,368 | 820,329,290 | 627,999,117 | 472,471,520 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 3,048,076,802 | 13,111,824,390 | 12,095,336,262 | 8,580,190,409 |
| 加:营业外收入 | 9,902,432 | 36,762,786 | 29,481,764 | 15,563,017 |
| 减:营业外支出 | 3,757,296 | 128,890,977 | 74,231,237 | 54,207,797 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 3,054,221,938 | 13,019,696,199 | 12,050,586,789 | 8,541,545,629 |
| 减:所得税费用 | 361,670,908 | 1,279,729,557 | 1,347,936,867 | 965,607,097 |
| 六、净利润 | 2,692,551,030 | 11,739,966,642 | 10,702,649,922 | 7,575,938,532 |
| 持续经营净利润 | 2,692,551,030 | 11,739,966,642 | 10,702,649,922 | 7,575,938,532 |
| 归属于母公司股东的净利润 | 2,628,580,553 | 11,668,487,164 | 10,637,075,305 | 7,560,737,744 |
| 少数股东损益 | 63,970,477 | 71,479,478 | 65,574,617 | 15,200,788 |
| (一)基本每股收益 | 2.17 | 9.64 | 8.78 | 6.24 |
| (二)稀释每股收益 | 2.17 | 9.63 | 8.78 | 6.24 |
| 八、其他综合收益 | 127,681,943 | -190,446,947 | -69,484,064 | -135,274,601 |
| 归属于母公司股东的其他综合收益 | 122,145,257 | -157,132,364 | -73,077,881 | -133,056,042 |
| 九、综合收益总额 | 2,820,232,973 | 11,549,519,695 | 10,633,165,858 | 7,440,663,931 |
| 归属于母公司股东的综合收益总额 | 2,750,725,810 | 11,511,354,800 | 10,563,997,424 | 7,427,681,702 |
| 归属于少数股东的综合收益总额 | 69,507,163 | 38,164,895 | 69,168,434 | 12,982,229 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-30 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |